Pharma Mar SA (PHMMF)
87.58
0.00 (0.00%)
USD |
OTCM |
Aug 21, 16:00
Pharma Mar Price : 87.58 for Aug. 21, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 87.58 | 87.58 | 87.58 | 87.58 | 0.000 |
| Aug 20, 2026 | 87.58 | 87.58 | 87.58 | 87.58 | 30.00 |
| Aug 19, 2026 | 87.58 | 87.58 | 87.58 | 87.58 | 0.000 |
| Aug 18, 2026 | 87.58 | 87.58 | 87.58 | 87.58 | 0.000 |
| Aug 17, 2026 | 87.58 | 87.58 | 87.58 | 87.58 | 0.000 |
| Aug 14, 2026 | 87.58 | 87.58 | 87.58 | 87.58 | 94.00 |
| Aug 13, 2026 | 87.58 | 87.58 | 87.58 | 87.58 | 7.000 |
| Aug 12, 2026 | 87.58 | 87.58 | 87.58 | 87.58 | 0.000 |
| Aug 11, 2026 | 87.58 | 87.58 | 87.58 | 87.58 | 30.00 |
| Aug 10, 2026 | 87.58 | 87.58 | 87.58 | 87.58 | 0.000 |
| Aug 07, 2026 | 87.58 | 87.58 | 87.58 | 87.58 | 15.00 |
| Aug 06, 2026 | 87.58 | 87.58 | 87.58 | 87.58 | 0.000 |
| Aug 05, 2026 | 87.58 | 87.58 | 87.58 | 87.58 | 300.00 |
| Aug 04, 2026 | 86.09 | 86.09 | 86.09 | 86.09 | 0.000 |
| Aug 03, 2026 | 86.09 | 86.09 | 86.09 | 86.09 | 4.000 |
| Jul 31, 2026 | 86.09 | 86.09 | 86.09 | 86.09 | 0.000 |
| Jul 30, 2026 | 86.09 | 86.09 | 86.09 | 86.09 | 0.000 |
| Jul 29, 2026 | 86.09 | 86.09 | 86.09 | 86.09 | 0.000 |
| Jul 28, 2026 | 86.09 | 86.09 | 86.09 | 86.09 | 16.00 |
| Jul 27, 2026 | 86.09 | 86.09 | 86.09 | 86.09 | 30.00 |
| Jul 24, 2026 | 86.09 | 86.09 | 86.09 | 86.09 | 41.00 |
| Jul 23, 2026 | 86.09 | 86.09 | 86.09 | 86.09 | 0.000 |
| Jul 22, 2026 | 86.09 | 86.09 | 86.09 | 86.09 | 0.000 |
| Jul 21, 2026 | 86.09 | 86.09 | 86.09 | 86.09 | 0.000 |
| Jul 20, 2026 | 86.09 | 86.09 | 86.09 | 86.09 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Oryzon Genomics SA | 3.36 |
| Grifols SA | 7.985 |
| ACADIA Pharmaceuticals, Inc. | 29.63 |
| Alkermes Plc | 48.85 |
| Alnylam Pharmaceuticals, Inc. | 236.06 |
Price Related Metrics
| PE Ratio | 23.41 |
| PS Ratio | 5.978 |
| PEG Ratio | 0.567 |
| Price to Book Value | 5.296 |
| Price to Free Cash Flow | 24.22 |
| Earnings Yield | 4.27% |
| Market Cap | 1.518B |
| PEGY Ratio | 0.5497 |
| Operating PE Ratio | 41.30 |
| Normalized PE Ratio | 23.41 |